Our Medical Experts
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Find a DoctorDelhi/NCR:
Mohali:
Dehradun:
Bathinda:
Mumbai:
Nagpur:
Lucknow:
BRAIN ATTACK:
To Book an Appointment
Call Us+91 926 888 0303Ductal carcinoma in situ (DCIS) is a type of non-invasive breast cancer that may progress to invasive ductal carcinoma over time if left untreated. For many people, a DCIS diagnosis means that they are facing an unknown and frightening future. At Max Hospitals, we strive to make it easier for the individuals diagnosed to make decisions about their treatment. Our team of specialists, including oncologists, provides a number of treatment strategies tailored to the current stage of DCIS and individual patient needs, with the goal of halting its development and alleviating any associated symptoms. Through our focused approach, patients can be confident of receiving appropriate treatment for DCIS.
Ductal Carcinoma in Situ is an abnormal growth of cells inside the milk ducts. It is considered a very early form of breast cancer and is referred to as non-invasive, pre-invasive, or stage 0 breast cancer. DCIS is one of the most treatable forms of breast cancer and can be treated with surgery or radiation therapy. However, if not diagnosed in time, it can spread to lymph nodes and then to other parts of the body, converting into invasive ductal carcinoma.
These mutations may result from a combination of genetic predisposition and environmental factors. Factors such as lifestyle, environment, and family history play a role in causing DNA mutations. However, no exact cause is not yet known, and research is still ongoing to find the reason behind these mutations.
Several factors are associated with the development of DCIS. These include:
DCIS does not usually cause any symptoms and is generally detected on a mammogram as tiny flecks of calcium in the breast tissue. These calcium deposits, known as microcalcifications, are often the first indicator of DCIS.
Some people may still experience the following symptoms:
DCIS diagnosis involves imaging tests and biopsy:
A mammogram provides higher-resolution images. It helps the doctor have a closer look at the calcium deposits in the breast tissue. These calcium deposits can sometimes turn cancerous.
Following a mammogram, a breast ultrasound may be ordered, which with the help of sound waves, provides clearer images of the breast tissue. Although not always required, an ultrasound can provide additional imaging information.
If any abnormalities are seen on imaging, the next procedure is generally a biopsy.
There are two types of biopsies: needle biopsy, in which a small tissue sample is taken using a needle, and surgical biopsy, where the sample is taken through a minor surgery. A pathologist then examines the cells under a microscope to determine if DCIS is present and, if so, what type it is.
DCIS is divided into three grades that directly reflect on the appearance and behaviour of the cancer cells:
The cancer cells in low-grade DCIS are slow-growing and only slightly different in appearance from normal cells. They are generally considered less dangerous and much less likely to become invasive carcinomas. Regular monitoring and treatment are still recommended to prevent progression. Low-grade DCIS may also show less abnormal cell activity seen in cancer.
In this grade, the cancer cells grow at an average rate. Intermediate-grade DCIS has a moderate risk of invasion if left untreated; hence, prompt treatment is advised.
High-grade DCIS cells look very different from normal cells and are more likely to divide and spread more rapidly than low-grade DCIS cells, making them a more serious type of cancer. Prompt intervention is essential to address the higher risk of progression to invasive cancer.
Surgery is the primary treatment for DCIS and involves the removal of abnormal cells from the breast. There are two types of surgery for DCIS:
Adjuvant radiation therapy is often prescribed after lumpectomy to destroy any remaining malignant cells in the breast tissue and lower the risk of DCIS recurrence. Radiation therapy is normally administered externally in small daily doses over several weeks. Modern advancements like intensity-modulated radiation therapy (IMRT) may help minimise side effects. Although radiation therapy reduces the risk of DCIS recurrence, it is not always required after mastectomy if the likelihood of its return is low.
Adjuvant systemic therapy may be recommended if the DCIS is hormone receptor-positive, meaning the cancer cells are stimulated by hormones like oestrogen. This therapy reduces the likelihood of DCIS recurrence and also lowers the risk of developing other types of breast cancer. Medications like tamoxifen or aromatase inhibitors are commonly prescribed for this purpose.
If left untreated, ductal carcinoma in situ can develop into invasive ductal cancer. It's critical to begin therapy as soon as possible after DCIS diagnosis.
People diagnosed with DCIS may be at higher risk of developing other health conditions, such as heart disease, high blood pressure, and osteoporosis. This is often due to shared risk factors or side effects of certain treatments like hormonal therapy.
Making modifications in everyday routine may help reduce the chance of ductal carcinoma in situ. These changes can include:
A good diet, frequent exercise, reducing alcohol consumption, and quitting smoking can all improve breast health and lower the risk of DCIS recurrence. However, no lifestyle change can guarantee that it will not recur. Regular medical follow-ups remain essential for monitoring.
Breast appearance may be impacted by procedures like mastectomy or lumpectomy. Options such as nipple-sparing mastectomy and partial reconstruction can help improve aesthetic outcomes. For those undergoing a mastectomy, breast reconstruction can often be performed during the same procedure or later, depending on individual preferences and health considerations.
The length of recovery varies based on personal health conditions and the type of surgery (mastectomy or lumpectomy). Many patients return to normal activities within a few weeks. Light activities like walking can often be resumed within a few days, but strenuous exercises should be avoided until cleared by the doctor. Following post-operative care instructions, such as proper wound care, activity restrictions, and attending follow-up appointments, is crucial for optimal recovery.
Physical examinations, routine mammograms, and, occasionally, imaging tests are all part of follow-up care. Lifestyle changes and adherence to prescribed medications, such as hormone therapy, may also be part of a comprehensive follow-up plan. The initial treatment approach, DCIS grade, and personal risk factors, all influence how frequently these follow-ups are conducted.
DCIS is classified as an early form of breast cancer. Treating DCIS early prevents the risk of invasive cancer, which can be harder to manage and pose greater health risks.
Reviewed By Dr. Sameer Khatri - Senior Director - Medical Oncology, Cancer Care / Oncology, Medical Oncology, Head & Neck Oncology, Gastrointestinal & Hepatobiliary Oncology on 19 Dec 2024.
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Find a Doctor